medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2022, Number 06

<< Back Next >>

Ginecol Obstet Mex 2022; 90 (06)

Chorea gravidarum secondary to Antiphospholipid Syndrome: Report of a case and review of the literature

Redondo-Villatoro A, Azcona-Sutil L, Corrales-Gutiérrez I, Fontán-Atalaya IM

Language: Spanish
References: 13
Page: 525-529
PDF size: 188.00 Kb.


ABSTRACT

Background: Chorea gravidarum has an estimated incidence of 1:2275 pregnancies. The differential diagnosis of this entity characterized by involuntary spontaneous movements together with behavioral alterations but be made with different neurological diseases. Generally, treatment of the underlying cause involves spontaneous cure of the condition.
Objective: To report the case of a patient who debuted with a chorea gravidarum secondary to antiphospholipid syndrome and to review the literature.
Case description: 37-years-old patient, 28 weeks pregnant, who consulted for behavioral alterations. Laboratory test showed elevated anti phospholipid and anti-beta 2 glycoprotein antibodies in two determinations 12 weeks apart, with negative ANCA and ANA. There was no pathological finding in brain magnetic resonance. She was diagnosed with corea gravidarum secondary to antiphospholipid syndrome. She was treated effectively with anticoagulants and corticosteroids, and is currently asymptomatic and without treatment.
Conclusions: Analytical and neuroimaging tests are helpful in establishing the etiology of chorea. anticoagulants are indicated to prevent thrombotic events in chorea secondary to antiphospholipid syndrome. Corticosteroids have variable efficacy in the control of neurological symptoms, although in our case complete remission of the symptoms will be overcome.


REFERENCES

  1. Germes-Piña F. Chorea gravidarum. A case report. GinecolObstet Mex 2009; 77 (3): 156-9.

  2. Rengifo-Quintero LJ, Beltrán-Avendaño MA. ChoreGravidum: Case report and review of the literature. RevColomb Obstet Ginecol 2019; 70 (3): 189-194. https://doi.org/10.18597/rcog.3251

  3. Rayego J, Suárez F. Corea. SEMERGEN-Medicina de Familia2008; 34 (6): 308-310. https://doi.org/10.1016/S1138-3593(08)71909-9

  4. Godínez-Baca LE, Lugo-Zamudio GE, Maya-Piña LV. Choreagravidarum associated with systemic lupus erythematosusand antiphospholipid syndrome: case report. CirCir 2020; 88 (Suppl 1): 59-62. https://doi.org/10.24875/CIRU.19001503

  5. Kranick SM, Mowry EM, Colher A, Horn S, et al. Movementdisorders and pregnancy: a review of the literature. MovDisord 2010; 25 (6): 665-71. https://doi.org/ 10.1002/mds.23071

  6. Sammaritano LR. Antiphospholipid syndrome. Best PractRes Clin Rheumatol 2020; 34 (1): 101463. https://doi.org/10.1016/j.berh.2019.101463

  7. Ricarte IF, Dutra LA, Abrantes FF, Toso FF, et al. Neurologicmanifestations of antiphospholipid syndrome.Lupus 2018; 27 (9): 1404-14. https://doi.org/10.1177/0961203318776110

  8. Qasim A. An unusual case of chorea gravidarum. PostgradMed J 2000; 76: 374-8. https://doi.org/10.1136/pmj.76.896.374

  9. Karageyim AY, Kars B, Dansuk R, Aygun E, et al. Chorea gravidarum:A case report. J Matern Fetal Neonatal Med 2002;12 (5): 353-4. https://doi.org/ 10.1080/jmf.12.5.353.354

  10. Palanivelu LM. Chorea gravidarum. J Obstet Gynaecol 2007;27 (3): 310. https://doi.org/10.1080 /01443610701241134

  11. Ghike S. A rare case of chorea gravidarum. JSAFOG2010; 2 (2): 145-146. https://doi.org/10.5005/jp-jounals-10006-1084.

  12. Kim A, Choi CH, Han CH, Shin JC. Consecutive pregnancywith chorea gravidarum associated with moyamoya disease.J Perinatol 2009; 29 (4): 317-9. https://doi.org/10.1038/jp.2008.183

  13. Pathania M, Upadhyaya S, Lali BS, Sharma A. Chorea gravidarum:A rarity in West still haunts pregnant women in theEast. BMJ Case Rep 2013; 2013: bcr2012008096 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703093/




2020     |     www.medigraphic.com